logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Search...
search
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Latest

Huacheck Medical (01931.HK) spent 5.076 million Hong Kong dollars on July 25 to repurchase 1.414 million shares.

date
29/07/2025
Zhitong Finance and Economics APP News, Huajian Medical (01931.HK) announced that on July 25, 2025, it spent HK$5.076 million to repurchase 1.414 million shares.
Latest
6 m ago
WTI crude oil surged by 3.00% intraday, now trading at $66.77 per barrel.
10 m ago
New York City Mayor Adams stated that the regulations require app companies to register with the Department of Transportation and assign a unique identification number to delivery personnel.
13 m ago
Sources say that Micro1, a competitor of Scale AI, is raising funding at a valuation of $500 million.
19 m ago
The US Department of Commerce is considering a new patent fee mechanism: charging 1-5% of the total patent value.
20 m ago
Anthropic announces: Flow restriction on Claude code.
See all latestmore
logo
Contact US
qr
+852 - 60190728
gmteight@futurecultural.com
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2025 GMT EIGHT Holdings. All Rights Reserved.